BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22673826)

  • 41. The validity of self-reported cancer diagnoses and factors associated with accurate reporting in a cohort of older Australian women.
    Stavrou E; Vajdic CM; Loxton D; Pearson SA
    Cancer Epidemiol; 2011 Dec; 35(6):e75-80. PubMed ID: 21474409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis.
    Rhee CW; Lee J; Oh S; Choi NK; Park BJ
    Osteoporos Int; 2012 Jan; 23(1):247-54. PubMed ID: 21431993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases.
    Lix LM; Yogendran MS; Leslie WD; Shaw SY; Baumgartner R; Bowman C; Metge C; Gumel A; Hux J; James RC
    J Clin Epidemiol; 2008 Dec; 61(12):1250-1260. PubMed ID: 18619800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone health-related factors and the use of bisphosphonates in community setting--15-year follow-up study.
    Sirola J; Salovaara K; Rikkonen T; Kärkkäinen M; Tuppurainen M; Jurvelin JS; Honkanen R; Kröger H
    Osteoporos Int; 2011 Jan; 22(1):255-64. PubMed ID: 20422155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).
    Cooper C; Jakob F; Chinn C; Martin-Mola E; Fardellone P; Adami S; Thalassinos NC; Melo-Gomes J; Torgerson D; Gibson A; Marin F
    Osteoporos Int; 2008 Apr; 19(4):493-501. PubMed ID: 17968611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of diabetes, heart disease, hypertension and stroke in mid- and older-aged women: Comparing self-report and administrative hospital data records.
    Navin Cristina TJ; Stewart Williams JA; Parkinson L; Sibbritt DW; Byles JE
    Geriatr Gerontol Int; 2016 Jan; 16(1):95-102. PubMed ID: 25613080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osteoporosis treatment and fracture incidence: the ICARO longitudinal study.
    Adami S; Isaia G; Luisetto G; Minisola S; Sinigaglia L; Silvestri S; Agnusdei D; Gentilella R; Nuti R;
    Osteoporos Int; 2008 Aug; 19(8):1219-23. PubMed ID: 18286217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for osteoporosis using easily obtainable biometrical data: diagnostic accuracy of measured, self-reported and recalled BMI, and related costs of bone mineral density measurements.
    van der Voort DJ; Brandon S; Dinant GJ; van Wersch JW
    Osteoporos Int; 2000; 11(3):233-9. PubMed ID: 10824239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™.
    Barrett-Connor E; Wade SW; Do TP; Satram-Hoang S; Stewart R; Gao G; Macarios D
    Osteoporos Int; 2012 Feb; 23(2):733-41. PubMed ID: 21625886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women.
    Pfeilschifter J; Cooper C; Watts NB; Flahive J; Saag KG; Adachi JD; Boonen S; Chapurlat R; Compston JE; Díez-Pérez A; LaCroix AZ; Netelenbos JC; Rossini M; Roux C; Sambrook PN; Silverman S; Siris ES
    Osteoporos Int; 2012 Aug; 23(8):2179-88. PubMed ID: 22086311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of 3-year raloxifene treatment in Japanese postmenopausal women aged 75 years or older with osteoporosis: a postmarketing surveillance study.
    Takeuchi Y; Hamaya E; Taketsuna M; Sowa H
    Menopause; 2015 Oct; 22(10):1134-7. PubMed ID: 25756692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women's Health Initiative Observational Study.
    Sullivan SD; Lehman A; Thomas F; Johnson KC; Jackson R; Wactawski-Wende J; Ko M; Chen Z; Curb JD; Howard BV
    Menopause; 2015 Oct; 22(10):1035-44. PubMed ID: 25803670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Kanis JA; McCloskey EV; Johansson H; Cooper C; Rizzoli R; Reginster JY;
    Osteoporos Int; 2013 Jan; 24(1):23-57. PubMed ID: 23079689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance.
    Brookhart MA; Avorn J; Katz JN; Finkelstein JS; Arnold M; Polinski JM; Patrick AR; Mogun H; Solmon DH
    Am J Med; 2007 Mar; 120(3):251-6. PubMed ID: 17349448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study.
    Modi A; Sen S; Adachi JD; Adami S; Cortet B; Cooper AL; Geusens P; Mellström D; Weaver JP; van den Bergh JP; Keown P; Sajjan S
    Osteoporos Int; 2018 Feb; 29(2):329-337. PubMed ID: 29110061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteoporosis/osteopenia as an independent factor associated with periodontitis in postmenopausal women: a case-control study.
    Passos JS; Vianna MI; Gomes-Filho IS; Cruz SS; Barreto ML; Adan L; Rösing CK; Cerqueira EM; Trindade SC; Coelho JM
    Osteoporos Int; 2013 Apr; 24(4):1275-83. PubMed ID: 23001114
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review.
    Fujiwara S; Miyauchi A; Hamaya E; Nicholls RJ; Weston A; Baidya S; Pinto L; Barron R; Takada J
    Arch Osteoporos; 2018 Mar; 13(1):34. PubMed ID: 29564555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postfracture care for older women: gaps between optimal care and actual care.
    Metge CJ; Leslie WD; Manness LJ; Yogendran M; Yuen CK; Kvern B;
    Can Fam Physician; 2008 Sep; 54(9):1270-6. PubMed ID: 18791104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of osteoporosis: are physicians missing an opportunity?
    Freedman KB; Kaplan FS; Bilker WB; Strom BL; Lowe RA
    J Bone Joint Surg Am; 2000 Aug; 82(8):1063-70. PubMed ID: 10954094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.
    Boonen S; Klemes AB; Zhou X; Lindsay R
    J Am Geriatr Soc; 2010 Apr; 58(4):658-63. PubMed ID: 20345865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.